Hnatowich DJ - Search Results

1

Pharmacokinetics of indium-111 labeled 10-3D2 antibreast-tumor antibody in patients.

Hnatowich DJ, Rusckowski M, Siebecker DA, Gionet M, Mardirossian G, Bushe HS, Roy S, Mattis JA, Shealy D, Griffin TW, et al. Hnatowich DJ, et al. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):7-13. J Nucl Biol Med (1991). 1992. PMID: 1450229

2

Localization of infection using streptavidin and biotin: an alternative to nonspecific polyclonal immunoglobulin.

Rusckowski M, Fritz B, Hnatowich DJ. Rusckowski M, et al. Among authors: hnatowich dj. J Nucl Med. 1992 Oct;33(10):1810-5. J Nucl Med. 1992. PMID: 1403148 Free article.

3

Long-term biodistribution in tumored mice of murine and chimeric B72.3-IgG antibody radiolabeled with 114mIn via both DTPA and a macrocyclic chelator.

Aas M, Mardirossian G, Griffin TW, Salimi AR, Ito T, Bushe HS, Atcher RW, Hines JJ, Brill AB, Hnatowich DJ. Aas M, et al. Among authors: hnatowich dj. J Nucl Biol Med (1991). 1992 Jan-Mar;36(1):33-40. J Nucl Biol Med (1991). 1992. PMID: 1450224

4

The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.

Mardirossian G, Wu C, Rusckowski M, Hnatowich DJ. Mardirossian G, et al. Among authors: hnatowich dj. Nucl Med Commun. 1992 Jul;13(7):503-12. doi: 10.1097/00006231-199207000-00005. Nucl Med Commun. 1992. PMID: 1495677

5

New indium-111 labeled biotin derivatives for improved immunotargeting.

Virzi F, Fritz B, Rusckowski M, Gionet M, Misra H, Hnatowich DJ. Virzi F, et al. Among authors: hnatowich dj. Int J Rad Appl Instrum B. 1991;18(7):719-26. doi: 10.1016/0883-2897(91)90010-i. Int J Rad Appl Instrum B. 1991. PMID: 1787080

6

Pharmacokinetics in patients of an anti-carcinoembryonic antigen antibody radiolabeled with indium-111 using a novel diethylenetriamine pentaacetic acid chelator.

Hnatowich DJ, Rusckowski M, Brill AB, Siebecker DA, Misra H, Mardirossian G, Bushe H, Rescigno A, Stevens S, Johnson DK, et al. Hnatowich DJ, et al. Cancer Res. 1990 Nov 15;50(22):7272-8. Cancer Res. 1990. PMID: 2224858

7

Patient biodistribution of intraperitoneally administered yttrium-90-labeled antibody.

Hnatowich DJ, Chinol M, Siebecker DA, Gionet M, Griffin T, Doherty PW, Hunter R, Kase KR. Hnatowich DJ, et al. J Nucl Med. 1988 Aug;29(8):1428-35. J Nucl Med. 1988. PMID: 3404257 Free article.

8

Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody.

Hnatowich DJ, Gionet M, Rusckowski M, Siebecker DA, Roche J, Shealy D, Mattis JA, Wilson J, McGann J, Hunter RE, et al. Hnatowich DJ, et al. Cancer Res. 1987 Nov 15;47(22):6111-7. Cancer Res. 1987. PMID: 3664510

9

Pharmacokinetics of an indium-111-labeled monoclonal antibody in cancer patients.

Hnatowich DJ, Griffin TW, Kosciuczyk C, Rusckowski M, Childs RL, Mattis JA, Shealy D, Doherty PW. Hnatowich DJ, et al. J Nucl Med. 1985 Aug;26(8):849-58. J Nucl Med. 1985. PMID: 3861793 Free article.

10

Directly and indirectly technetium-99m-labeled antibodies--a comparison of in vitro and animal in vivo properties.

Hnatowich DJ, Mardirossian G, Rusckowski M, Fogarasi M, Virzi F, Winnard P Jr. Hnatowich DJ, et al. J Nucl Med. 1993 Jan;34(1):109-19. J Nucl Med. 1993. PMID: 8418250 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters